IGM Biosciences (STU:1K0) Total Assets : €346.04 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is IGM Biosciences Total Assets?

IGM Biosciences's Total Assets for the quarter that ended in Mar. 2024 was €346.04 Mil.

During the past 12 months, IGM Biosciences's average Total Assets Growth Rate was -7.80% per year. During the past 3 years, the average Total Assets Growth Rate was 26.50% per year. During the past 5 years, the average Total Assets Growth Rate was 85.40% per year.

During the past 7 years, IGM Biosciences's highest 3-Year average Total Assets Growth Rate was 253.60%. The lowest was 26.50%. And the median was 126.55%.

Total Assets is connected with ROA %. IGM Biosciences's annualized ROA % for the quarter that ended in Mar. 2024 was -49.93%. Total Assets is also linked to Revenue through Asset Turnover. IGM Biosciences's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

IGM Biosciences Total Assets Historical Data

The historical data trend for IGM Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGM Biosciences Total Assets Chart

IGM Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

235.22

335.90

263.84

484.74

388.27

IGM Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															432.20	443.65	444.47	388.27	346.04

IGM Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

IGM Biosciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	186.366	+	201.902
	=	388.27

IGM Biosciences's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	148.353	+	197.689
	=	346.04

IGM Biosciences (STU:1K0) Total Assets Explanation

Total Assets is connected with ROA %.

IGM Biosciences's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-183.324	/	( (388.268	+	346.041)	/ 2 )
	=	-183.324	/	367.1545
	=	-49.93 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

IGM Biosciences's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.457	/	( (388.268	+	346.041)	/ 2 )
=	0.457	/	367.1545
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

IGM Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of IGM Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

IGM Biosciences (STU:1K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGM Biosciences Inc (STU:1K0) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

IGMS:USA

Address

325 East Middlefield Road, Mountain View, CA, USA, 94043

Website

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

IGM Biosciences (STU:1K0) Headlines

No Headlines